NL-OMON53756招募中4 期
*Prevention of opioid-induced constipation in patients with advanced cancer* - OMAMA-study
Amsterdam UMC0 个研究点目标入组 330 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 330
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with advanced cancer (>=18 years);
- •Starting with slow release or transdermal opioids for pain;
- •Able to complete a Dutch questionnaire.
- •Previous treatment with opioids is allowed, if discontinued more than 4 weeks
排除标准
- •Patients with contra-indications for laxatives • Maintenance treatment with
- •laxatives during the last two weeks • Severely impaired renal function (serum
- •creatinine >180 umol/l) • Estimated life expectancy <1 month
研究者
相似试验
尚未招募
4 期
Prevention of opioid-associated constipation in ventilated intensive care patientsConstipationOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonAnaesthesiology - Pain managementACTRN12620000207910Dr Eamon Raith300
招募中
1 期
Prevention of opioid-induced constipation in patients with advanced cancerOpioid-induced constipation in patients with advanced cancer, starting with opioids for painMedDRA version: 24.0Level: LLTClassification code 10071128Term: Opioid induced constipationSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2022-000408-36-NLZonMw330
招募中
Unknown
Observational study on opioid-induced constipation in patients with non-cancer chronic pain using weak opioid analgesics in JapaOpioid Induced ConstipationJPRN-UMIN000050203Shionogi & Co., Ltd.60
进行中（未招募）
不适用
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesEUCTR2007-007610-10-NLMC Utrecht
已完成
3 期
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesConstipation/difficulty with bowel movements10017977NL-OMON33671niversitair Medisch Centrum Utrecht155